Staar Surgical Company (STAA)
$17.40 -0.20 (-1.14%)Market Cap | 868.12M |
Revenue (ttm) | 313.90M |
Net Income (ttm) | -20.21M |
EPS (ttm) | N/A |
PE Ratio | 0.00 |
Forward PE | N/A |
Profit Margin | -6.44% |
Debt to Equity Ratio | 0.00 |
Volume | 1,414,800 |
Avg Vol | 1,164,478 |
Day's Range | N/A - N/A |
Shares Out | 49.33M |
Stochastic %K | 32% |
Beta | 0.75 |
Analysts | Sell |
Price Target | $18.86 |
Latest News on STAA

Mar 17, 2025, 6:30 PM EDT - 17 days ago
STAAR Surgical Announces Realignment of Leadership Structure

Mar 2, 2025, 11:00 AM EST - 4 weeks ago
The Schall Law Firm Invites Shareholders With Losses In STAAR Surgical Company To Join A Securities Fraud Investigation

Feb 27, 2025, 10:00 AM EST - 5 weeks ago
Bronstein, Gewirtz & Grossman, LLC Encourages STAAR Surgical Company (STAA) Shareholders to Inquire about Securities Investigation

Feb 26, 2025, 10:00 AM EST - 5 weeks ago
Bronstein, Gewirtz & Grossman, LLC Is Investigating STAAR Surgical Company (STAA) And Encourages Shareholders to Connect

Feb 25, 2025, 10:00 AM EST - 5 weeks ago
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against STAAR Surgical Company (STAA) And Encourages Shareholders to Reach Out


Feb 23, 2025, 10:00 AM EST - 5 weeks ago
STAAR Surgical Company (STAA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Feb 21, 2025, 10:00 AM EST - 5 weeks ago
Bronstein, Gewirtz & Grossman, LLC Is Investigating STAAR Surgical Company (STAA) And Encourages Investors to Connect

Feb 20, 2025, 10:00 AM EST - 6 weeks ago
Bronstein, Gewirtz & Grossman, LLC Encourages STAAR Surgical Company (STAA) Stockholders to Inquire about Securities Investigation

Feb 19, 2025, 10:00 AM EST - 6 weeks ago
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against STAAR Surgical Company (STAA) and Encourages Investors to Learn More About the Investigation

Feb 18, 2025, 9:29 PM EST - 6 weeks ago
STAA Investors Have Opportunity to Join STAAR Surgical Company Fraud Investigation with the Schall Law Firm


Feb 17, 2025, 10:00 AM EST - 6 weeks ago
Bronstein, Gewirtz & Grossman, LLC Encourages STAAR Surgical Company (STAA) Investors to Inquire about Securities Investigation

Feb 16, 2025, 10:00 AM EST - 6 weeks ago
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against STAAR Surgical Company (STAA) And Encourages Investors to Reach Out

Feb 14, 2025, 10:00 AM EST - 6 weeks ago
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against STAAR Surgical Company (STAA) And Encourages Stockholders to Reach Out

Feb 13, 2025, 10:00 AM EST - 7 weeks ago
Bronstein, Gewirtz & Grossman, LLC Is Investigating STAAR Surgical Company (STAA) And Encourages Stockholders to Connect

Feb 13, 2025, 1:52 AM EST - 7 weeks ago
STAAR Surgical Company (STAA) Q4 2024 Earnings Call Transcript

Feb 12, 2025, 10:40 AM EST - 7 weeks ago
Eye Lens Maker Staar Surgical Stock Sinks As Sales Drop To $49 Million, Analyst Downgrades

Feb 12, 2025, 10:10 AM EST - 7 weeks ago
STAAR Surgical Q4: Ongoing Challenges In China Masks Healthy Growth Elsewhere

Feb 11, 2025, 4:01 PM EST - 7 weeks ago
STAAR Surgical Reports Fourth Quarter and Fiscal Year 2024 Results

Jan 31, 2025, 10:38 AM EST - 2 months ago
STAAR Surgical: Growth Story Remains Intact Despite Some Challenges

Jan 13, 2025, 7:00 AM EST - 2 months ago
STAAR Surgical to Host Fourth Quarter and Fiscal Year 2024 Earnings Conference Call and Webcast on February 19, 2025